Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Aspirin and ovarian cancer: An Italian case-control study
Autore:
Tavani, A; Gallus, S; La Vecchia, C; Conti, E; Montella, M; Franceschi, S;
Indirizzi:
Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy Mario Negri Inst Pharmacol Res Milan Italy I-20157 I-20157 Milan, Italy Univ Milan, Ist Stat Med & Biometria, I-20122 Milan, Italy Univ Milan Milan Italy I-20122 tat Med & Biometria, I-20122 Milan, Italy Ist Regina Elena Studio & Cura Tumori, Serv Epidemiol & Oncogenesi, Rome, Italy Ist Regina Elena Studio & Cura Tumori Rome Italy ncogenesi, Rome, Italy Ist Tumori Fdn Pascale, Serv Epidemiol, Naples, Italy Ist Tumori Fdn Pascale Naples Italy cale, Serv Epidemiol, Naples, Italy Int Agcy Res Canc, Field & Intervent Studies Unit, F-69372 Lyon, France Int Agcy Res Canc Lyon France F-69372 Studies Unit, F-69372 Lyon, France
Titolo Testata:
ANNALS OF ONCOLOGY
fascicolo: 9, volume: 11, anno: 2000,
pagine: 1171 - 1173
SICI:
0923-7534(200009)11:9<1171:AAOCAI>2.0.ZU;2-V
Fonte:
ISI
Lingua:
ENG
Soggetto:
RHEUMATOID-ARTHRITIS; INCESSANT OVULATION; RISK; ANALGESICS;
Keywords:
aspirin; inflammation; NSAID; ovarian neoplasms; pharmacoepidemiology; risk factors; salicylates;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
13
Recensione:
Indirizzi per estratti:
Indirizzo: Tavani, A Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy Mario Negri Inst Pharmacol Res Via Eritrea 62 Milan Italy I-20157
Citazione:
A. Tavani et al., "Aspirin and ovarian cancer: An Italian case-control study", ANN ONCOL, 11(9), 2000, pp. 1171-1173

Abstract

Background: A role for inflammation, and consequently of non-steroideal anti-inflammatory drugs, in ovarian carcinogenesis has been proposed, but epidemiological evidence is scanty. Patients and methods: Data were derived from a hospital-based case-controlstudy conducted in Italy between 1992 and 1999. Cases were 749 women, aged18-80 years (median age 56 years), with incident, histologically confirmedovarian cancer. Controls were 898 non-hysterectomized women, aged 17-80 years (median age 58 years), admitted to hospital for acute conditions, unrelated to risk factors for ovarian cancer. Results: The multivariate odds ratio (OR) was 0.93 (95% confidence interval (95% CI): 0.53-1.62) for regular aspirin use for more than six months, 1.38 (95% CI: 0.57-3.36) for current use and 0.72 (95% CI: 0.35-1.47) for former use. The OR was not significantly different from unity for duration of use, age at starting use, indication (analgesia or cardiovascular prevention), and in women aged < 60 and greater than or equal to 60 years at ovariancancer diagnosis. Conclusions: This study provides little support for the hypothesis that aspirin may reduce the risk of ovarian cancer.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/20 alle ore 09:49:42